British Patient Capital Overview
- Investor Type
-
Fund of Funds
- Status
-
Active
- Professionals
-
24
- Investments
-
30
- Portfolio
-
26
British Patient Capital General Information
Company Description
Established in 2018, British Patient Capital is primarily an investor in UK focused venture capital funds. The firm makes direct investments in UK R&D intensive scale-up companies raising a minimum of £30m.
Business Details
Website
www.britishpatientcapital.co.ukYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Steel City House
- West Street
- Sheffield S1 2GQ
- England, United Kingdom
British Patient Capital Investments (30)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Form3 | 10-Sep-2024 | Later Stage VC | Financial Software | Generating Revenue | ||
Epsilogen | 09-Sep-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Myricx Bio | 08-Jul-2024 | Drug Discovery | Generating Revenue | |||
Wagestream | 17-Apr-2024 | Financial Software | Generating Revenue | |||
Grey Wolf Therapeutics | 06-Mar-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
Phagenesis | 04-Mar-2024 | Therapeutic Devices | Generating Revenue | |||
Curve Therapeutics | 27-Feb-2024 | Drug Discovery | Product Development | |||
Pragmatic | 05-Dec-2023 | Application Specific Semiconductors | Generating Revenue | |||
Tenpoint Therapeutics | 12-Jul-2023 | Early Stage VC | Drug Discovery | Startup | ||
Quantexa | 04-Apr-2023 | Later Stage VC | Business/Productivity Software | Generating Revenue |
British Patient Capital Investments by Industry, Year, and Region
British Patient Capital Management, Team & Partners (36)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Tom Haywood | Managing Director, Direct Investments | Sheffield, United Kingdom | |||
Christine Hockley | Managing Director, Funds | Sheffield, United Kingdom | |||
Natalie Bangay | Director | London, United Kingdom | |||
George Mills | Director, Deeptech and Co-Investment | London, United Kingdom | |||
Michael Laycock | Director, Funds | Sheffield, United Kingdom |
British Patient Capital Co-Investors (176)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Oxford Science Enterprises | 5 | ||||
IP Group | |||||
In-Q-Tel | |||||
Molten Ventures | |||||
Pfizer Ventures |
British Patient Capital FAQs
-
What is British Patient Capital?
Established in 2018, British Patient Capital is primarily an investor in UK focused venture capital funds.
-
When was British Patient Capital founded?
British Patient Capital was founded in 2018.
-
Where is British Patient Capital headquartered?
British Patient Capital is headquartered in Sheffield, United Kingdom.
-
What is British Patient Capital's total asset value?
British Patient Capital has around
in total assets under management. -
How many investments has British Patient Capital made?
British Patient Capital has made 30 investments.
-
What has British Patient Capital invested in?
British Patient Capital has made numerous investments in companies like Form3, Epsilogen, and Myricx Bio within the Financial Software and Drug Discovery industries.
-
What has British Patient Capital invested in recently?
British Patient Capital's latest investment was on 10-Sep-2024 in Form3, a company within the Financial Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »